Skip to main navigation Skip to search Skip to main content

Symptomatic cerebrospinal fluid HIV-1 escape in two patients on second-line antiretroviral therapy in Uganda

  • Kenneth Ssebambulidde
  • , Ivan Segawa
  • , Eva Laker
  • , Mohammed Lamorde
  • , Barbara Castelnouvo
  • , Noeline Nakasujja
  • , Andrea CALCAGNO

Research output: Contribution to journalArticlepeer-review

Abstract

Two HIV-infected individuals on second-line atazanavir-based antiretroviral therapy presented with neuropsychiatric symptoms. Cerebrospinal fluid HIV RNA was higher than plasma HIV RNA and antiretroviral regimens' optimization led to prompt resolution of symptoms in one. Patients on second-line atazanavir-based antiretroviral therapy with documented previous treatment failure may be at risk of symptomatic cerebrospinal fluid escape.
Original languageEnglish
Pages (from-to)79-82
Number of pages4
JournalOxford Medical Case Reports
Volume2019
Issue number2
DOIs
Publication statusPublished - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Symptomatic cerebrospinal fluid HIV-1 escape in two patients on second-line antiretroviral therapy in Uganda'. Together they form a unique fingerprint.

Cite this